|
Genomas is a biomedical company advancing DNA-Guided Medicine and personalized healthcare. The
company develops revolutionary PhyzioTypeTM Systems for DNA-guided management and prescription of
drugs used to treat mental illness and diabetes. PhyzioType Systems are designed to provide physicians with
an unprecedented capability to select for each patient the safest and most effective drug to achieve treatment
goals and enhance patient compliance. PhyzioType Systems are composed of an ensemble of inherited DNA
polymorphisms genotyped by arrays and interpreted by a bioclinical algorithm in order to convey to physicians
predicted comparisons of side effect risk and efficacy among drugs for the individual patient.
The company’s clinical pharmacogenetic tests and consultation service are provided through its Laboratory of
Personalized Health (LPH), an accredited and licensed high-complexity molecular diagnostic center and its
Personalized Health Portal (PHP), a medical informatics interface for clinician decision support. Genomas is
located on the campus of Hartford Hospital in downtown Hartford, Connecticut.
| 
